|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Product Patent vs. Process Patent, Protection of right to Ipr and right to life in India (pharmaceutical industry) |
| Authors Name: | Victoria Thakur |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_201419
|
| Published Paper Id: | IJNRD2307150 |
| Published In: | Volume 8 Issue 7, July-2023 |
| DOI: | http://doi.one/10.1729/Journal.35189 |
| Abstract: | Among all the assets found under intellectual property rights, patents tend to be extensively sought by inventors and industries. This is because it gives them the right to prevent others from using, manufacturing, or even making a product by a similar technique. The patent right has been given the first position in the most developed countries, benefiting the pharmaceutical industry. For instance, their patent regime in India has been significant for the generic drug industry's development, enhancing the availability and production of critical drugs at affordable prices. A product patent is intended to protect an investor’s product. This is facilitated by providing a safeguard to the original innovator to ease competition toward a similar product. Whereas, a process patent is primarily used to protect the procedures via which one produces the product and not the product itself. This kind of protection helps in reducing the monopoly element within the market. Therefore, as India practices intellectual property rights laws, all its members must change their patent to product from the patent process. The point remains to find out what is unique about a product patent that is not within a process patent. Under the product patent, exclusive rights are provided to the original innovator of the product. Its attributes include; the provision of monopoly rights to the product's creator. They are termed to be at a high level of protection compared to process patents, where its grant depicts that no person apart from the innovator has the mandate to manufacture a similar product by utilizing a similar process. Unlike in process patents, where the process regime is offered to only a specific process but not the final product. It differs from the product patent because another manufacturer can create a similar product using a different process, it provides a lower range of investor protection, and a single product can have multiple process patents. Therefore, the development of the pharmaceutical industry has emerged due to a regime connected to patents that have positively impacted India. The country acts as the leading medicine supplier to developing countries, making it known as a doctor with no borders. Earlier Indian pharmaceutical industries were using process patents where different industries would produce generic drugs on massive levels, facilitating access to developing and underdeveloped countries. Thus, introducing product patent laws meant that Indian pharmaceutical industries would not manufacture medicines through reverse engineering until the patent became in use. This study aims to add to the existing knowledge on the difference between product and process patents. And so,, to achieve the aim of the study, secondary research was carried out by reviewing existing literature from journals, articles, and even scholarly works to provide evidence. Inclusion and exclusion criteria were adopted to decide what articles to include in the study. |
| Keywords: | LEGAL, PHARMACEUTICAL, PATENT |
| Cite Article: | "Product Patent vs. Process Patent, Protection of right to Ipr and right to life in India (pharmaceutical industry) ", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 7, page no.b440-b446, July-2023, Available :http://www.ijnrd.org/papers/IJNRD2307150.pdf |
| Downloads: | 000118764 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2307150 Registration ID: 201419 Published In: Volume 8 Issue 7, July-2023 DOI (Digital Object Identifier): http://doi.one/10.1729/Journal.35189 Page No: b440-b446 Country: Noida, Uttar Pradesh, India Research Area: Other Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2307150 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2307150 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn